• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与细胞毒性药物相关的特发性门静脉高压症。

Idiopathic portal hypertension associated with cytotoxic drugs.

作者信息

Shepherd P, Harrison D J

机构信息

Department of Haematology, Western General Hospital, Edinburgh.

出版信息

J Clin Pathol. 1990 Mar;43(3):206-10. doi: 10.1136/jcp.43.3.206.

DOI:10.1136/jcp.43.3.206
PMID:2332518
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC502331/
Abstract

Four patients developed clinically important portal hypertension with histological features of idiopathic portal hypertension while they were receiving cytotoxic drugs for chronic myeloid leukaemia and Hodgkin's disease. Mild sclerosis of some small portal triads was the only abnormality seen at light microscopical examination in three of the four cases. In the remaining case light microscopical findings seemed to be normal. Two cases examined by electron microscopy showed perisinusoidal fibrosis; in one case this was the only abnormality detected. There is an association between idiopathic portal hypertension and the use of chemotherapeutic agents, particularly thioguanine. Adequate histological examination of liver tissue, including electron microscopic studies, is recommended for patients who develop hepatic problems while receiving cytotoxic treatment to elucidate this problem.

摘要

四名患者在接受治疗慢性粒细胞白血病和霍奇金病的细胞毒性药物期间,出现了具有特发性门静脉高压组织学特征的临床上重要的门静脉高压。在这四名患者中的三名患者中,光镜检查仅发现一些小门静脉三联征轻度硬化。在其余病例中,光镜检查结果似乎正常。两例经电子显微镜检查显示肝窦周围纤维化;其中一例这是检测到的唯一异常。特发性门静脉高压与化疗药物的使用之间存在关联,尤其是硫鸟嘌呤。对于在接受细胞毒性治疗时出现肝脏问题的患者,建议进行包括电子显微镜研究在内的肝组织充分组织学检查,以阐明这个问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c1d/502331/6309e0a6d7c7/jclinpath00393-0033-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c1d/502331/a25738f99ca2/jclinpath00393-0031-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c1d/502331/142c75a4c7e3/jclinpath00393-0032-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c1d/502331/626db6d882ae/jclinpath00393-0032-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c1d/502331/6309e0a6d7c7/jclinpath00393-0033-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c1d/502331/a25738f99ca2/jclinpath00393-0031-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c1d/502331/142c75a4c7e3/jclinpath00393-0032-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c1d/502331/626db6d882ae/jclinpath00393-0032-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c1d/502331/6309e0a6d7c7/jclinpath00393-0033-a.jpg

相似文献

1
Idiopathic portal hypertension associated with cytotoxic drugs.与细胞毒性药物相关的特发性门静脉高压症。
J Clin Pathol. 1990 Mar;43(3):206-10. doi: 10.1136/jcp.43.3.206.
2
Thioguanine used in maintenance therapy of chronic myeloid leukaemia causes non-cirrhotic portal hypertension. Results from MRC CML. II. Trial comparing busulphan with busulphan and thioguanine.用于慢性髓性白血病维持治疗的硫鸟嘌呤会导致非肝硬化性门静脉高压。医学研究委员会慢性髓性白血病II期试验结果:比较白消安与白消安加硫鸟嘌呤的疗效。
Br J Haematol. 1991 Oct;79(2):185-92. doi: 10.1111/j.1365-2141.1991.tb04520.x.
3
Idiopathic portal hypertension (perisinusoidal fibrosis) after renal transplantation.肾移植后特发性门静脉高压症(窦周纤维化)
Gut. 1979 Jun;20(6):531-7. doi: 10.1136/gut.20.6.531.
4
Portal hypertension in a patient with chronic myeloid leukaemia.一名慢性髓性白血病患者的门静脉高压症
Postgrad Med J. 1977 May;53(619):267-9. doi: 10.1136/pgmj.53.619.267.
5
Long-term follow-up of children with 6-thioguanine-related chronic hepatoxicity following treatment for acute lymphoblastic leukaemia.急性淋巴细胞白血病治疗后 6-硫鸟嘌呤相关慢性肝毒性患儿的长期随访。
J Pediatr Gastroenterol Nutr. 2011 Nov;53(5):478-9. doi: 10.1097/MPG.0b013e31822960e9.
6
Chemotherapy during Pregnancy: Cases of Hodgkin's and Non-Hodgkin's Lymphoma, Chronic Myeloid Leukemia, Breast Cancer, Nasopharyngeal Cancer, and Choriocarcinoma.妊娠期化疗:霍奇金淋巴瘤和非霍奇金淋巴瘤、慢性髓性白血病、乳腺癌、鼻咽癌和绒毛膜癌病例。
Oncol Res Treat. 2017;40(7-8):441-445. doi: 10.1159/000473880. Epub 2017 Jul 13.
7
Oesophageal varices associated with busulphan-thioguanine combination therapy for chronic myeloid leukaemia.白消安-硫鸟嘌呤联合疗法治疗慢性粒细胞白血病相关的食管静脉曲张
Lancet. 1987 Nov 7;2(8567):1050-2. doi: 10.1016/s0140-6736(87)91478-4.
8
Pathology of idiopathic non-cirrhotic portal hypertension.特发性非肝硬化性门静脉高压症的病理学。
Virchows Arch. 2018 Jul;473(1):23-31. doi: 10.1007/s00428-018-2355-8. Epub 2018 Apr 12.
9
Prevalence of histological features of idiopathic noncirrhotic portal hypertension in general population: a retrospective study of incidental liver biopsies.一般人群中特发性非肝硬化性门静脉高压的组织学特征的流行情况:偶然肝活检的回顾性研究。
Hepatol Int. 2017 Sep;11(5):452-460. doi: 10.1007/s12072-017-9801-6. Epub 2017 Jun 8.
10
Chronic oral arsenic intoxication as a possible aetiological factor in idiopathic portal hypertension (non-cirrhotic portal fibrosis) in India.慢性口服砷中毒作为印度特发性门静脉高压症(非肝硬化性门静脉纤维化)的一种可能病因。
Gut. 1979 May;20(5):378-84. doi: 10.1136/gut.20.5.378.

引用本文的文献

1
Portal hypertension and refractory ascites associated with multicentric Castleman's disease.门静脉高压症和难治性腹水与多中心性Castleman病相关。
Dig Dis Sci. 2000 Apr;45(4):697-702. doi: 10.1023/a:1005483308015.
2
"Endemic" idiopathic portal hypertension: report on 32 patients with non-cirrhotic portal fibrosis.“地方性”特发性门静脉高压症:32例非肝硬化性门静脉纤维化患者的报告
World J Surg. 1992 Jan-Feb;16(1):118-24; discussion 124-5. doi: 10.1007/BF02067126.

本文引用的文献

1
Nodular regenerative hyperplasia of the liver in hematologic disorders: a possible response to obliterative portal venopathy. A morphometric study of nine cases with an hypothesis on the pathogenesis.血液系统疾病中的肝脏结节性再生性增生:对闭塞性门静脉病的一种可能反应。9例病例的形态计量学研究及发病机制假说
Medicine (Baltimore). 1980 Sep;59(5):367-79.
2
Antineoplastic agents and the liver.抗肿瘤药物与肝脏
Gastroenterology. 1980 Jan;78(1):142-64.
3
Nodular transformation (nodular "regenerative" hyperplasia) of the liver. A clinicopathologic study of 30 cases.
肝脏的结节状转化(结节性“再生性”增生)。30例临床病理研究。
Hum Pathol. 1981 Jan;12(1):60-71. doi: 10.1016/s0046-8177(81)80242-0.
4
Liver pathology of idiopathic portal hypertension. Comparison with non-cirrhotic portal fibrosis of India. The Japan idiopathic portal hypertension study.特发性门静脉高压症的肝脏病理学。与印度非肝硬化性门脉纤维化的比较。日本特发性门静脉高压症研究。
Liver. 1982 Sep;2(3):176-92. doi: 10.1111/j.1600-0676.1982.tb00195.x.
5
Intrahepatic portal vein sclerosis in patients without a history of liver disease. An autopsy study.无肝脏疾病病史患者的肝内门静脉硬化。一项尸检研究。
Am J Pathol. 1982 Jan;106(1):63-70.
6
Extra- and intrahepatic portal hypertension without cirrhosis (hepatoportal sclerosis).无肝硬化的肝内外门静脉高压症(肝门静脉硬化症)
Ann Surg. 1965 Oct;162(4):602-20. doi: 10.1097/00000658-196510000-00006.
7
Ultrastructure of the liver in non-cirrhotic portal fibrosis with portal hypertension.伴有门静脉高压的非肝硬化性门静脉纤维化的肝脏超微结构
Gut. 1970 Nov;11(11):905-10. doi: 10.1136/gut.11.11.905.
8
Noncirrhotic portal fibrosis.非肝硬化性门脉纤维化
Am J Med. 1971 Aug;51(2):160-9. doi: 10.1016/0002-9343(71)90234-8.
9
Hepatic injury from chronic hypervitaminosis a resulting in portal hypertension and ascites.慢性维生素A过多症导致的肝损伤,进而引起门静脉高压和腹水。
N Engl J Med. 1974 Aug 29;291(9):435-40. doi: 10.1056/NEJM197408292910903.
10
Arsenic and noncirrhotic portal hypertension.砷与非肝硬化性门静脉高压症
Gastroenterology. 1974 Jan;66(1):86-94.